Chronic wound-related pain is a complex biopsychosocial experience that is experienced spontaneously at rest and exacerbated during activities. Tissue debridement, trauma at dressing change, increased bioburden or infection, exposure of periwound skin to moisture, and related treatment can modulate chronic wound-related pain. Clinicians should consider multimodal and multidisciplinary management approach that take into account the biology, emotions, cognitive thinking, social environment, and other personal determinants of pain. Unresolved pain can have a significant impact on wound healing, patients' adherence to treatment, and individual's quality of life.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cger.2023.12.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The provision of wound care and management in a community healthcare setting: an exploratory study.
J Wound Care
January 2025
Nursing and Health Care, School of Health Sciences, South East Technological University, Waterford City, Ireland.
Objective: Wound management can be costly and challenging to the health services' scarce resources. Information regarding the number of wounds in a community care setting and their associated aetiology will provide nurses and nurse managers with an insight into the specific needs of these clients with wounds and highlight areas where care or services can be improved or further developed. This research aimed to establish the prevalence and aetiology of wounds, the current delivery of wound care, wound documentation and referral pathways in an Irish community care setting.
View Article and Find Full Text PDFOnce daily Bromelain-based enzymatic debridement of venous leg ulcers versus gel vehicle (placebo) and non-surgical standard of care: a three-arm multicenter, double blinded, randomized controlled study.
EClinicalMedicine
September 2024
Department of Plastic and Reconstructive Surgery, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheba, Israel.
Background: Debridement is considered the first step in treatment of chronic wounds, however, current enzymatic and autolytic debridement agents are slow or ineffective. Previous studies have shown positive initial results with EscharEx® (EX-02 formulation), a Bromelain-based enzymatic debridement agent in development for chronic wounds. The main objective of this study was to assess its efficacy in debriding venous leg ulcers (VLU), compared to gel vehicle (GV) as a placebo control and to non-surgical standard of care (NSSOC).
View Article and Find Full Text PDFWound-related Pain and Quality of Life in Patients with Chronic Wounds in a Metropolitan City in Nigeria: An Analytic Cross-sectional Study.
J West Afr Coll Surg
July 2024
Department of Plastic, Reconstructive and Aesthetic Surgery, University College Hospital, Ibadan, Nigeria.
Background: The prevalence of chronic wounds is expected to rise with the increasing elderly population in the society. This rise in prevalence of chronic wounds comes with its consequences such as wound pain and interference with activities of daily living. There's a paucity of data on the impact of chronic wounds in our clime.
View Article and Find Full Text PDFBeyond antibiotics: mesenchymal stem cells and bacteriophages-new approaches to combat bacterial resistance in wound infections.
Mol Biol Rep
December 2024
Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran.
Article Synopsis
- * Chronic wounds particularly affect elderly and diabetic patients, often requiring repeated medical interventions to avoid complications like infections that can have severe local and systemic effects.
- * The article focuses on innovative treatments for wound healing and infection management, specifically the potential of bacteriophages and mesenchymal stem cells in improving healing processes and combating infections.
HUC-MSCs combined with platelet lysate treat diabetic chronic cutaneous ulcers in Bama miniature pig.
Regen Ther
June 2024
Department of Endocrinology & Metabolism, West China Hospital of Sichuan University, Chengdu, China.
Article Synopsis
- Human umbilical cord mesenchymal stem cells (HUC-MSCs) combined with platelet lysate (PL) demonstrate significant potential for improving wound healing, especially in diabetic conditions.
- The study involved both in vitro and in vivo experiments, using high glucose cultured cells to simulate diabetic chronic ulcers and treating created wounds in pigs with various combinations of PL and HUC-MSCs.
- Results showed that the PL + HUC-MSCs treatment achieved the best healing outcomes by enhancing collagen formation, neovascularization, and regulating inflammation-related factors compared to the other treatment groups.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!